Yakob Liawatidewi Amphastar Pharmaceuticals, Inc. (AMPH) insider trading activity

Yakob Liawatidewi is EVP CORP ADMIN CENTER of Amphastar Pharmaceuticals, Inc.. Currently has a direct ownership of 74,938 shares of AMPH, which is worth approximately $2.78 Million. The most recent transaction as insider was on Jun 14, 2022, when has been sold 128 shares (Common Stock) at a price of $31.02 per share, resulting in proceeds of $3,971. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 74.9K

0% 3M change

7.56% 12M change

Total Value Held $2.78 Million

Yakob Liawatidewi Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 14 2022	SELL Payment of exercise price or tax liability	$3,971 $31.02 p/Share	128 Reduced 0.21%	61,607 Common Stock
Jun 04 2022	SELL Payment of exercise price or tax liability	$9,971 $37.77 p/Share	264 Reduced 0.43%	61,735 Common Stock
Mar 17 2022	SELL Payment of exercise price or tax liability	$57,183 $34.18 p/Share	1,673 Reduced 2.68%	60,740 Common Stock
Mar 16 2022	SELL Payment of exercise price or tax liability	$55,402 $34.22 p/Share	1,619 Reduced 2.53%	62,413 Common Stock
Mar 15 2022	SELL Payment of exercise price or tax liability	$54,160 $34.74 p/Share	1,559 Reduced 2.38%	64,032 Common Stock
Mar 15 2022	BUY Grant, award, or other acquisition	-	11,514 Added 14.93%	65,591 Common Stock
Aug 02 2021	SELL Open market or private sale	$188,822 $21.14 p/Share	8,932 Reduced 14.18%	54,077 Common Stock
Aug 02 2021	BUY Exercise of conversion of derivative security	$133,533 $14.95 p/Share	8,932 Added 12.42%	63,009 Common Stock
Jul 15 2021	SELL Open market or private sale	$630,795 $20.01 p/Share	31,524 Reduced 36.83%	54,077 Common Stock
Jul 15 2021	BUY Exercise of conversion of derivative security	$409,233 $13.19 p/Share	31,026 Added 26.6%	85,601 Common Stock
Jun 14 2021	SELL Payment of exercise price or tax liability	$2,519 $19.68 p/Share	128 Reduced 0.23%	54,575 Common Stock
Jun 04 2021	SELL Payment of exercise price or tax liability	$4,961 $18.79 p/Share	264 Reduced 0.48%	54,703 Common Stock
May 17 2021	SELL Open market or private sale	$192,644 $19.99 p/Share	9,637 Reduced 15.25%	53,573 Common Stock
May 17 2021	BUY Exercise of conversion of derivative security	$109,187 $11.33 p/Share	9,637 Added 13.23%	63,210 Common Stock
May 14 2021	SELL Open market or private sale	$63,465 $19.92 p/Share	3,186 Reduced 5.61%	53,573 Common Stock
May 12 2021	SELL Open market or private sale	$88,763 $19.33 p/Share	4,592 Reduced 7.48%	56,759 Common Stock
May 11 2021	SELL Open market or private sale	$190,600 $19.06 p/Share	10,000 Reduced 14.02%	61,351 Common Stock
May 11 2021	BUY Exercise of conversion of derivative security	$113,300 $11.33 p/Share	10,000 Added 12.29%	71,351 Common Stock
Mar 17 2021	BUY Grant, award, or other acquisition	-	19,344 Added 23.97%	61,351 Common Stock
Mar 16 2021	SELL Payment of exercise price or tax liability	$44,809 $18.44 p/Share	2,430 Reduced 5.47%	42,007 Common Stock
Mar 15 2021	SELL Payment of exercise price or tax liability	$29,855 $19.15 p/Share	1,559 Reduced 3.39%	44,437 Common Stock

Yakob Liawatidewi

EVP CORP ADMIN CENTER

Rancho Cucamonga, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMPH shares.

Notify only if

Value

Insider Trading

Get notified when an Amphastar Pharmaceuticals, Inc. insider buys or sells AMPH shares.

Notify only if

Operation

Value

Type

News

Receive news related to Amphastar Pharmaceuticals, Inc.

Track Activities on AMPH

Account